Who is the MPCCC?
Monash Partners Comprehensive Cancer Consortium (MPCCC) is a network of hospitals and universities working together to advance cancer care through research.

Our contemporary partnership connects eight of Victoria’s largest public and private cancer health services with Monash University’s world leading research and education. 

Led by a team of internationally renowned researchers, our goal is to work together to link ideas and resources, share our discoveries and work at scale to drive improvements in cancer care for a diverse population of over 2.1 million Victorians.

What do we do?
MPCCC’s collaborative research programs target real life problems for our consumers that are changing the shape of cancer prevention, diagnosis and treatment.

Our network of health professionals and researchers are making breakthrough scientific discoveries, developing the next generation of diagnostic tools and leading clinical trials to improve patient care. Learning from each other and sharing our knowledge is key.

Why do we exist?
Our mission is to ensure patients across our network have equitable access to the most up to date evidence-based cancer care and resources.

Together, we will change the future of cancer in Victoria.

Our Priorities
We believe cancer research and service improvement are integrally linked and should be driven by the needs and priorities of the community. Our mission is to build a culture of collaboration and innovation that transcends organisational boundaries and drives improved cancer outcomes. MPCCC priorities are to:

Design and deliver a holistic and equitable cancer research and improvement agenda.

Build capacity for innovations in cancer treatment by linking discovery, pre-clinical and clinical research.

Drive improvements in cancer through the strategic use of data to inform priorities and measure outcomes.

Establish and maintain strategic collaborations that align cancer research and improvement activities with health and research policy agenda.

Use appropriate governance and processes to lead and promote a world-class cancer research and improvement agenda.